Navigation Links
National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
Date:5/1/2012

HAMPTON, Va., May 1, 2012 /PRNewswire-USNewswire/ -- The National Patient Advocate Foundation (NPAF) today applauded the Delaware General Assembly and Governor Jack Markell for approving and signing into law legislation that will help Delaware's insured cancer patients access their physician-prescribed anti-cancer medications of choice. The Delaware Cancer Treatment Access Act (House Bill 265), sponsored by Representative Deborah Hudson (R-12), will create parity in insurance coverage for oral anti-cancer medications and was signed into law today at a ceremony in Dover attended by bill supporters, members of the cancer community and patient advocates, including NPAF representatives.

"We thank Rep. Hudson and the Delaware General Assembly for taking this important step to help the state's cancer patients who have been struggling to access the prescribed oral anti-cancer medications that they prefer," said Nancy Davenport-Ennis, founder and CEO of the Patient Advocate Foundation (PAF) and National Patient Advocate Foundation. "Thanks to the enactment of this legislation, Delaware's physicians and cancer patients will be better able to make treatment decisions based on the best treatment protocol for each individual's particular case."

Although oral anti-cancer medications are increasingly available for treating various types of cancer and patients often prefer it to intravenous (IV) chemotherapy, insurance coverage can be a hindrance to patients' access to these treatments. Because health insurance plans often cover oral anti-cancer medications under prescription drug coverage, which is generally not as comprehensive or financially feasible as coverage for IV drugs, this disparity in coverage can leave many cancer patients with no choice but to sit for hours at a time in a cancer care facility while they undergo physically difficult IV treatments.

With the enactment of the Delaware Cancer Treatment Access Act, Delaware's group and individual health insurance plans will now be required to provide coverage for oral anti-cancer medications at a cost to the patient that is no greater than the cost of intravenous or injectable chemotherapy agents, thus providing greater opportunity for cancer patients to secure these medications taken at home.  

"We thank Rep. Hudson and Delaware's lawmakers for coming together in a bipartisan manner to provide equal opportunity for cancer patients who are seeking oral anti-cancer medications," noted Larry Lanier, Executive Vice President of State Government Affairs for NPAF. "By enacting this measure, insured patients in Delaware fighting cancer will be able access the anti-cancer treatment of their choice without cost being an unrealistic barrier."


'/>"/>
SOURCE National Patient Advocate Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
2. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
3. Chindex International, Inc. to Report First Quarter 2012 Financial Results
4. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
5. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
6. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
7. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
8. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
9. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
10. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
11. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  Agenovir Corporation, a company ... antiviral therapeutics, today announced that it appointed ... and a member of the board of directors. ... with a deep background in both founding and ... of Agenovir, co-president of Chan Zuckerberg  Biohub ...
(Date:12/8/2016)... NORWALK, Conn. , Dec. 8, 2016   Mederi Therapeutics Inc . has ... for Stretta Therapy, a non-surgical treatment for chronic gastroesophageal reflux disease (GERD). ... ... procedure performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , "We ...
(Date:12/8/2016)... ANTONIO , Dec. 8, 2016 Eli ... announced that the neoMONARCH study of abemaciclib, a cyclin-dependent ... primary endpoint of reducing expression of Ki67, a biomarker ... data from the Phase 2 trial presented during the ... Cancer Symposium (SABCS) evaluated abemaciclib, both alone or in ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) ... per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical Benchmarks ... (WCRI) . , According to the study, medical payments per claim in California decreased ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial planning services from offices headquartered in Little Rock, has initiated a charity ... According to the National Foundation to End Senior Hunger, Arkansas ranks first in ...
(Date:12/8/2016)... FL (PRWEB) , ... December 08, 2016 , ... Coppin ... business owners and families in and around the Cape Coral area, is embarking on ... Chapin Food Bank of Southwest Florida. , The Harry Chapin Food Bank of Southwest ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication to ... of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of ... both sides of the Atlantic with a mechanism to comply with EU data protection ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
Breaking Medicine News(10 mins):